Acute unilateral myopia induced by add-on aripiprazole: A case report

Psychiatrists should keep in mind that unilateral myopia as a side effect may develop after combining aripiprazole with fluoxetine in patients with OCD and MDD.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:The partial agonist aripiprazole is a novel atypical antipsychotic with a relatively safer side effect profile.

📊

Key Findings & Data:She was on fluoxetine (Prozac) 80 mg/day when adding aripiprazole (Abilify) 10 mg/day as an augmentation agent has triggered unilateral myopia.

💡

Conclusion & Impact:Psychiatrists should keep in mind that unilateral myopia as a side effect may develop after combining aripiprazole with fluoxetine in patients with OCD and MDD.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

The partial agonist aripiprazole is a novel atypical antipsychotic with a relatively safer side effect profile. Acute unilateral myopia is a very rare condition that is commonly associated with drug use. Here, we present a woman diagnosed with obsessive-compulsive disorder (OCD) and major depressive disorder (MDD) who have been treated for two years in our clinic. She was on fluoxetine (Prozac) 80 mg/day when adding aripiprazole (Abilify) 10 mg/day as an augmentation agent has triggered unilateral myopia. After cessation of aripirazole her myopia has disappeared. Psychiatrists should keep in mind that unilateral myopia as a side effect may develop after combining aripiprazole with fluoxetine in patients with OCD and MDD.

🔖

Cite This Article

GÜNEŞ, M., DEMİR, S., BULUT, M., KAYA, M. C., ATLİ, A., IBİLOGLU, A. O., YUKSEL, H. (2022). Acute unilateral myopia induced by add-on aripiprazole: A case report. Klinik Psikofarmakoloji Bülteni, Cilt: 26 - Sayı: 1, 68–71. https://ajindex.com/articles/573909

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, et al. Aripiprazole, a novel antipsychotic, is a high affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002;302(1):381-9. [CrossRef] 2. Gupta S, Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry 2004;16(3):155-66. [CrossRef] 3. DeLeon A, Patel NC, Crismon ML. Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clin Ther 2004;26(5):649-66. [CrossRef] 4. Bovino JA, Marcus DF. The mechanism of transient myopia induced by sulfonamide therapy. Am J Ophthalmol 1982;94(1):99-102. [CrossRef] 5. Gubbay SS. The occurrence of drug-induced myopia as a transient side effect of topiramate. Epilepsia 1998;39(4):451. [CrossRef] 6. Brunton L, Chabner B, Knollman B. Goodman and Gillman's The Pharmacological Basis of Therapeutics. 12th ed. New York: Mc Graham-Hill Companies; 2011. p. 583-607. 7. Dorell K, Cohen MA, Huprikar SS, Gorman JM, Jones M. Citalopram-induced diplopia. Psychosomatics 2005;46(1):91-3. [CrossRef] 8. Sener EC, Kiratli H. Presumed sertraline maculopathy. Acta Ophthalmol Scand 2001;79(4):428-30. [CrossRef] 9. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 2003;61(2-3):123-36. [CrossRef] 10. Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo controlled 26-week study. J Clin Psychiatry 2003;64(9):1048-56. [CrossRef] 11. Selvi Y, Atli A, Aydin A, Yener HI. Aripiprazole-related acute transient myopia and diplopia: a case report. J Clin Psychopharmacol 2011;31(2):249-50. [CrossRef] 12. Nair AG, Nair AG, George RJ, Biswas J, Gandhi RA. Aripiprazole induced transient myopia: a case report and review of literature. Cutan Ocul Toxicol 2012;31(1):74-6. [CrossRef] 13. Atli A, Selvi Y, Yildiz A, Kaya MC. Aripiprozole-Induced diplopia: a case report. Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2013;23(4):353-6. [CrossRef] 14. Shah P, Dhurjon L, Metcalfe T, Gibson JM. Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol. BMJ 1992;304(6818):40-1. [CrossRef] 15. Krieg PH, Schipper I. Drug-induced ciliary body edema: a new theory. Eye 1996;1